The original shots don’t hold up against infection By Nicole Wetsman Pfizer and BioNTech are launching a clinical trial to test an omicron-specific version of their COVID-19 vaccine, the companies announced today. They’re moving forward with studies of a new form of...
If further study confirms the findings, they could lead to ways to prevent and treat the complex condition. By Pam Belluck It is one of many mysteries about long Covid: Who is more prone to developing it? Are some people more likely than others to experience physical,...
By OREGON HEALTH & SCIENCE UNIVERSITY OHSU laboratory research compares routes to immunity involving vaccination. New laboratory research from Oregon Health & Science University reveals more than one path toward robust immunity from COVID-19. A new study...
In November, Australia’s Dr. Nikolai Petrovsky from Flinders University recently visited TrialSite to discuss the progress associated with his vaccine company, Vaxine. The renowned researcher, professor, and expert in the field of...
A professional body for general practitioners (physicians) in the United Kingdom, the Royal College of General Practitioners (RCGP) represents general practitioners (GPs) on key issues from licensing and education to research and clinical standards and...
A new study shows that a reduction in the quarantine period to five days may be too premature and not enough to protect the vulnerable population. The International Journal of Infectious Diseases on Dec. 7 released results online from their study...
— There's an urgent need to prepare for future variants by Anna Bershteyn, PhD The narrative around Omicron is full of resignation. Be cautious, but don't panic. Get vaccinated, test often, reschedule what you're willing to, but don't aim for zero risk. That...
By Judd Legum The Omicron variant appears somewhat less severe than previous strains of COVID-19, but it is still landing plenty of Americans — especially the unvaccinated — in the hospital. At present, more than 155,000 people with COVID are hospitalized, which is a...
BY MONIQUE BEALS Medicines Patent Pool, an organization supported by the U.N., announced on Thursday that over two dozen generic drug makers will soon begin producing Merck's COVID-19 pill to make the treatment more accessible in developing...
By Peter Doshi, senior editor British Medical Journal with comments by Mark Bricca, ND Scientific integrity and ethics demand that data concerning the largest worldwide clinical trial ever be made available for analysis by scientists and researchers outside of pharma...
What’s next? By David Leonhardt The latest Omicron developments continue to be encouraging. New Covid-19 cases are plummeting in a growing list of places. The percentage of cases causing severe illness is much lower than it was with the Delta variant. And vaccines —...
A research team led by Professor Hongzhe Sun, Norman & Cecilia Yip Professor in Bioinorganic Chemistry from the Department of Chemistry, Faculty of Science, the University of Hong Kong (HKU), in collaboration with Dr. Shuofeng Yuan, Assistant Professor from the...
By Nicholas Wade | Originally Published May 5, 2021 in Bulletin of Atomic Scientists Nicholas Wade is a science writer, editor, and author who has worked on the staff of Nature, Science, and, for many years, the New York Times... The COVID-19 pandemic has disrupted...
Robert Malone claims to have invented mRNA technology. Why is he trying so hard to undermine its use?By Tom Bartlett Originally published in The Atlantic ~ August 12, 2021 Robert Malone—a medical doctor and an infectious-disease researcher—recently suggested that the...
A study led by corresponding author Paul Kuodi with the Faculty of Medicine at Bar-Ilan University, Israel and the Galilee Medical Center, uncovered what appears as potentially good news. Still in preprint mode—the study shouldn’t be cited as evidence—it nonetheless,...